Valuation: Abbott Laboratories

Market Cap 16TCr 14TCr 13TCr 12TCr 22TCr 14,98300Cr 22TCr 1,49900Cr 59TCr 7,31700Cr 58TCr 57TCr 25,26000Cr P/E 2026 *
22.1x
P/E 2027 * 19.1x
Enterprise Value 16TCr 14TCr 13TCr 12TCr 23TCr 15,76100Cr 23TCr 1,57700Cr 62TCr 7,69600Cr 61TCr 60TCr 26,57100Cr EV / Sales 2026 *
3.24x
EV / Sales 2027 * 2.94x
Free-Float
86.73%
Yield 2026 *
2.86%
Yield 2027 * 3.05%
1 day+16.59%
3 months-24.71%
6 months-30.19%
Current year-30.19%
Current year 72.68
Extreme 72.68
98.39
1 year 72.68
Extreme 72.68
98.39
3 years 72.68
Extreme 72.68
110.91
5 years 72.68
Extreme 72.68
110.91
10 years 72.68
Extreme 72.68
110.91
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+16.59%0.00% - - 16TCr
+1.77%+1.43%-6.92%-3.62% 10TCr
+1.72%+1.69%+3.27%+60.08% 5.77TCr
-1.11%+4.77%+38.09%+52.37% 5.23TCr
-0.18%+6.01%-10.30%-37.69% 4.27TCr
+3.69%+0.69% - - 3.34TCr
+4.30%+6.70%-7.39%-43.32% 2.81TCr
-2.52%+1.00%+60.99%-5.84% 2.54TCr
-0.85%+8.07%-4.63%-18.66% 2.1TCr
+6.64%+2.30%-2.93%-3.24% 2.06TCr
Average +4.20%+0.39%+8.77%+0.01% 4.27TCr
Weighted average by Cap. +6.86%-0.52%+6.30%+6.84%

Financials

2026 *2027 *
Net sales 5.04TCr 4.41TCr 4.08TCr 3.74TCr 7.08TCr 4,86000Cr 7.2TCr 49TCr 19TCr 2,37400Cr 19TCr 19TCr 8,19400Cr 5.47TCr 4.78TCr 4.43TCr 4.06TCr 7.69TCr 5,27500Cr 7.82TCr 53TCr 21TCr 2,57600Cr 21TCr 20TCr 8,89300Cr
Net income 700.46Cr 612.27Cr 566.23Cr 519.59Cr 983.39Cr 67TCr 1TCr 6.75TCr 2.65TCr 33TCr 2.63TCr 2.57TCr 1,13800Cr 828.5Cr 724.19Cr 669.73Cr 614.56Cr 1.16TCr 80TCr 1.18TCr 7.99TCr 3.14TCr 39TCr 3.11TCr 3.04TCr 1,34600Cr
Net Debt 806.84Cr 705.26Cr 652.23Cr 598.5Cr 1.13TCr 78TCr 1.15TCr 7.78TCr 3.06TCr 38TCr 3.03TCr 2.96TCr 1,31100Cr 545.49Cr 476.82Cr 440.96Cr 404.64Cr 765.82Cr 53TCr 779.13Cr 5.26TCr 2.07TCr 26TCr 2.05TCr 2TCr 89TCr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
89.27USD
Average target price
116.54USD
Spread / Average Target
+30.55%

Quarterly revenue - Rate of surprise